Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11555019 Peptide conjugates of microtubule-targeting agents as therapeutics

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
July 9, 2020
Date of Patent
January 17, 2023
Patent Application Number
16924445
Patent Citations
‌
US Patent 10383878 Anti-HER3 antibody-drug conjugate
‌
US Patent 10413615 Process for preparing cell-binding agent-cytotoxic agent conjugates
‌
US Patent 10435432 Preparation of maytansinoid antibody conjugates by a one-step process
‌
US Patent 10695396 Malignant tumor target peptide
‌
US Patent 10844135 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said
‌
US Patent 10729782 Antibody-drug conjugate produced by binding through linker having hydrophilic structure
‌
US Patent 10933069 Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
‌
US Patent 10064855 Composite nanoparticles and uses thereof
‌
US Patent 10195288 Antibody-drug conjugate
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11555019
Patent Primary Examiner
‌
Daniel R Carcanague
CPC Code
‌
C07D 265/12

Find more entities like US Patent 11555019 Peptide conjugates of microtubule-targeting agents as therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo